ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mebendazole API Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-25K13988
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mebendazole API Market Research Report 2023
BUY CHAPTERS

Global Mebendazole API Market Research Report 2025

Code: QYRE-Auto-25K13988
Report
June 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Cipla Ltd
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Anant Pharmaceuticals
FENGCHEN GROUP CO., LTD
Solara Active Pharma Sciences
Conscientia Industrial Co., Ltd
K. A. Malle
Optimus Drugs Pvt LTD
Enomark Pharma
Sudarshan Pharma Industries Limited
Dolphinpharma
Jiangsu Quality Horizons Pharmtech Co., Ltd.
Eurosoft Pharma Private Limited

Mebendazole API Market Size

The global market for Mebendazole API was valued at US$ 91 million in the year 2024 and is projected to reach a revised size of US$ 115 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Mebendazole API Market

Mebendazole API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Mebendazole API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Mebendazole API (Active Pharmaceutical Ingredient) is a synthetic benzimidazole derivative used as the core component in medications designed to treat parasitic worm infections (helminthiasis). It functions by binding to tubulin in parasitic cells, inhibiting microtubule synthesis and disrupting glucose uptake, ultimately leading to energy depletion and the death of the worms. This broad-spectrum anthelmintic is effective against a range of intestinal parasites, including roundworms (Ascaris), hookworms (Necator americanus, Ancylostoma duodenale), whipworms (Trichuris trichiura), pinworms (Enterobius vermicularis), and certain species of tapeworms. Mebendazole API is typically formulated into oral tablets or suspensions for human use, and its purity, potency, and quality are strictly regulated to meet pharmacopoeial standards (e.g., USP, EP) for safe and effective therapeutic use. It is a key component in over-the-counter and prescription treatments for parasitic infestations, particularly in regions with high prevalence of soil-transmitted helminths, and is valued for its efficacy across different life stages of parasites and relatively low toxicity in humans when used as directed.
The mebendazole API industry is experiencing several notable trends. Mebendazole, a broad - spectrum anthelmintic, is crucial for treating parasitic worm infestations such as pinworm, roundworm, whipworm, and hookworm. One of the significant drivers of this growth is the high prevalence of parasitic infections globally. The World Health Organization (WHO) reports that over 1.5 billion people are affected by soil - transmitted helminth infections, creating a large demand for affordable treatments like mebendazole. In regions such as Africa, Asia, and Latin America, where poor sanitation and limited healthcare access are prevalent, the need for mebendazole is particularly acute. As the global population grows and urbanization increases, these infections remain a significant concern, further driving the demand for mebendazole. The availability of generic mebendazole has been a game - changer in improving access to this essential medication, especially in low - income regions. Moreover, its inclusion in essential medicine lists, such as the WHO's list, contributes significantly to its sales. Innovations in drug formulations are also a trend. Mebendazole is being introduced in different forms like chewable tablets and syrups, which increases its appeal, particularly among pediatric patients. However, the mebendazole API industry also faces competition from other anthelmintics such as albendazole and levamisole, as well as combination treatments that may offer broader protection against parasitic infections.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mebendazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mebendazole API.
The Mebendazole API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mebendazole API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mebendazole API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mebendazole API Market Report

Report Metric Details
Report Name Mebendazole API Market
Accounted market size in year US$ 91 million
Forecasted market size in 2031 US$ 115 million
CAGR 3.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Purity≥99%
  • Purity<99%
Segment by Application
  • Tablet
  • Solvent
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dolphinpharma, Anant Pharmaceuticals, Fengchen Group Co.,Ltd, Solara Active Pharma Sciences, Conscientia Industrial Co., Ltd, Cipla, K.A.Malle, Optimus Drugs Pvt Ltd, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd, Jiangsu Quality Horizons Pharmtech Co., Ltd., Enomark Pharma, Eurosoft Pharma Private Limited, Sudarshan Pharma Industries Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mebendazole API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mebendazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Mebendazole API Market growing?

Ans: The Mebendazole API Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Mebendazole API Market size in 2031?

Ans: The Mebendazole API Market size in 2031 will be US$ 115 million.

Who are the main players in the Mebendazole API Market report?

Ans: The main players in the Mebendazole API Market are Dolphinpharma, Anant Pharmaceuticals, Fengchen Group Co.,Ltd, Solara Active Pharma Sciences, Conscientia Industrial Co., Ltd, Cipla, K.A.Malle, Optimus Drugs Pvt Ltd, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd, Jiangsu Quality Horizons Pharmtech Co., Ltd., Enomark Pharma, Eurosoft Pharma Private Limited, Sudarshan Pharma Industries Limited

What are the Application segmentation covered in the Mebendazole API Market report?

Ans: The Applications covered in the Mebendazole API Market report are Tablet, Solvent, Others

What are the Type segmentation covered in the Mebendazole API Market report?

Ans: The Types covered in the Mebendazole API Market report are Purity≥99%, Purity<99%

Recommended Reports

API Ingredient Markets

Anthelmintic & Deworming

Anti-infective Drugs

1 Mebendazole API Market Overview
1.1 Product Definition
1.2 Mebendazole API by Type
1.2.1 Global Mebendazole API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Mebendazole API by Application
1.3.1 Global Mebendazole API Market Value by Application (2024 VS 2031)
1.3.2 Tablet
1.3.3 Solvent
1.3.4 Others
1.4 Global Mebendazole API Market Size Estimates and Forecasts
1.4.1 Global Mebendazole API Revenue 2020-2031
1.4.2 Global Mebendazole API Sales 2020-2031
1.4.3 Global Mebendazole API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mebendazole API Market Competition by Manufacturers
2.1 Global Mebendazole API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mebendazole API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mebendazole API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mebendazole API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mebendazole API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mebendazole API, Product Type & Application
2.7 Global Key Manufacturers of Mebendazole API, Date of Enter into This Industry
2.8 Global Mebendazole API Market Competitive Situation and Trends
2.8.1 Global Mebendazole API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mebendazole API Players Market Share by Revenue
2.8.3 Global Mebendazole API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mebendazole API Market Scenario by Region
3.1 Global Mebendazole API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mebendazole API Sales by Region: 2020-2031
3.2.1 Global Mebendazole API Sales by Region: 2020-2025
3.2.2 Global Mebendazole API Sales by Region: 2026-2031
3.3 Global Mebendazole API Revenue by Region: 2020-2031
3.3.1 Global Mebendazole API Revenue by Region: 2020-2025
3.3.2 Global Mebendazole API Revenue by Region: 2026-2031
3.4 North America Mebendazole API Market Facts & Figures by Country
3.4.1 North America Mebendazole API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mebendazole API Sales by Country (2020-2031)
3.4.3 North America Mebendazole API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mebendazole API Market Facts & Figures by Country
3.5.1 Europe Mebendazole API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mebendazole API Sales by Country (2020-2031)
3.5.3 Europe Mebendazole API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mebendazole API Market Facts & Figures by Region
3.6.1 Asia Pacific Mebendazole API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mebendazole API Sales by Region (2020-2031)
3.6.3 Asia Pacific Mebendazole API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mebendazole API Market Facts & Figures by Country
3.7.1 Latin America Mebendazole API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mebendazole API Sales by Country (2020-2031)
3.7.3 Latin America Mebendazole API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mebendazole API Market Facts & Figures by Country
3.8.1 Middle East and Africa Mebendazole API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mebendazole API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mebendazole API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mebendazole API Sales by Type (2020-2031)
4.1.1 Global Mebendazole API Sales by Type (2020-2025)
4.1.2 Global Mebendazole API Sales by Type (2026-2031)
4.1.3 Global Mebendazole API Sales Market Share by Type (2020-2031)
4.2 Global Mebendazole API Revenue by Type (2020-2031)
4.2.1 Global Mebendazole API Revenue by Type (2020-2025)
4.2.2 Global Mebendazole API Revenue by Type (2026-2031)
4.2.3 Global Mebendazole API Revenue Market Share by Type (2020-2031)
4.3 Global Mebendazole API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mebendazole API Sales by Application (2020-2031)
5.1.1 Global Mebendazole API Sales by Application (2020-2025)
5.1.2 Global Mebendazole API Sales by Application (2026-2031)
5.1.3 Global Mebendazole API Sales Market Share by Application (2020-2031)
5.2 Global Mebendazole API Revenue by Application (2020-2031)
5.2.1 Global Mebendazole API Revenue by Application (2020-2025)
5.2.2 Global Mebendazole API Revenue by Application (2026-2031)
5.2.3 Global Mebendazole API Revenue Market Share by Application (2020-2031)
5.3 Global Mebendazole API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dolphinpharma
6.1.1 Dolphinpharma Company Information
6.1.2 Dolphinpharma Description and Business Overview
6.1.3 Dolphinpharma Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dolphinpharma Mebendazole API Product Portfolio
6.1.5 Dolphinpharma Recent Developments/Updates
6.2 Anant Pharmaceuticals
6.2.1 Anant Pharmaceuticals Company Information
6.2.2 Anant Pharmaceuticals Description and Business Overview
6.2.3 Anant Pharmaceuticals Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Anant Pharmaceuticals Mebendazole API Product Portfolio
6.2.5 Anant Pharmaceuticals Recent Developments/Updates
6.3 Fengchen Group Co.,Ltd
6.3.1 Fengchen Group Co.,Ltd Company Information
6.3.2 Fengchen Group Co.,Ltd Description and Business Overview
6.3.3 Fengchen Group Co.,Ltd Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fengchen Group Co.,Ltd Mebendazole API Product Portfolio
6.3.5 Fengchen Group Co.,Ltd Recent Developments/Updates
6.4 Solara Active Pharma Sciences
6.4.1 Solara Active Pharma Sciences Company Information
6.4.2 Solara Active Pharma Sciences Description and Business Overview
6.4.3 Solara Active Pharma Sciences Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Solara Active Pharma Sciences Mebendazole API Product Portfolio
6.4.5 Solara Active Pharma Sciences Recent Developments/Updates
6.5 Conscientia Industrial Co., Ltd
6.5.1 Conscientia Industrial Co., Ltd Company Information
6.5.2 Conscientia Industrial Co., Ltd Description and Business Overview
6.5.3 Conscientia Industrial Co., Ltd Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Conscientia Industrial Co., Ltd Mebendazole API Product Portfolio
6.5.5 Conscientia Industrial Co., Ltd Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cipla Mebendazole API Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 K.A.Malle
6.7.1 K.A.Malle Company Information
6.7.2 K.A.Malle Description and Business Overview
6.7.3 K.A.Malle Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 K.A.Malle Mebendazole API Product Portfolio
6.7.5 K.A.Malle Recent Developments/Updates
6.8 Optimus Drugs Pvt Ltd
6.8.1 Optimus Drugs Pvt Ltd Company Information
6.8.2 Optimus Drugs Pvt Ltd Description and Business Overview
6.8.3 Optimus Drugs Pvt Ltd Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Optimus Drugs Pvt Ltd Mebendazole API Product Portfolio
6.8.5 Optimus Drugs Pvt Ltd Recent Developments/Updates
6.9 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
6.9.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Company Information
6.9.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Description and Business Overview
6.9.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Mebendazole API Product Portfolio
6.9.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Recent Developments/Updates
6.10 Jiangsu Quality Horizons Pharmtech Co., Ltd.
6.10.1 Jiangsu Quality Horizons Pharmtech Co., Ltd. Company Information
6.10.2 Jiangsu Quality Horizons Pharmtech Co., Ltd. Description and Business Overview
6.10.3 Jiangsu Quality Horizons Pharmtech Co., Ltd. Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu Quality Horizons Pharmtech Co., Ltd. Mebendazole API Product Portfolio
6.10.5 Jiangsu Quality Horizons Pharmtech Co., Ltd. Recent Developments/Updates
6.11 Enomark Pharma
6.11.1 Enomark Pharma Company Information
6.11.2 Enomark Pharma Description and Business Overview
6.11.3 Enomark Pharma Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Enomark Pharma Mebendazole API Product Portfolio
6.11.5 Enomark Pharma Recent Developments/Updates
6.12 Eurosoft Pharma Private Limited
6.12.1 Eurosoft Pharma Private Limited Company Information
6.12.2 Eurosoft Pharma Private Limited Description and Business Overview
6.12.3 Eurosoft Pharma Private Limited Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Eurosoft Pharma Private Limited Mebendazole API Product Portfolio
6.12.5 Eurosoft Pharma Private Limited Recent Developments/Updates
6.13 Sudarshan Pharma Industries Limited
6.13.1 Sudarshan Pharma Industries Limited Company Information
6.13.2 Sudarshan Pharma Industries Limited Description and Business Overview
6.13.3 Sudarshan Pharma Industries Limited Mebendazole API Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sudarshan Pharma Industries Limited Mebendazole API Product Portfolio
6.13.5 Sudarshan Pharma Industries Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mebendazole API Industry Chain Analysis
7.2 Mebendazole API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mebendazole API Production Mode & Process Analysis
7.4 Mebendazole API Sales and Marketing
7.4.1 Mebendazole API Sales Channels
7.4.2 Mebendazole API Distributors
7.5 Mebendazole API Customer Analysis
8 Mebendazole API Market Dynamics
8.1 Mebendazole API Industry Trends
8.2 Mebendazole API Market Drivers
8.3 Mebendazole API Market Challenges
8.4 Mebendazole API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Cipla Ltd
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Anant Pharmaceuticals
FENGCHEN GROUP CO., LTD
Solara Active Pharma Sciences
Conscientia Industrial Co., Ltd
K. A. Malle
Optimus Drugs Pvt LTD
Enomark Pharma
Sudarshan Pharma Industries Limited
Dolphinpharma
Jiangsu Quality Horizons Pharmtech Co., Ltd.
Eurosoft Pharma Private Limited
List of Tables
 Table 1. Global Mebendazole API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mebendazole API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mebendazole API Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mebendazole API Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Mebendazole API Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mebendazole API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mebendazole API Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mebendazole API Average Price (US$/kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mebendazole API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mebendazole API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mebendazole API, Product Type & Application
 Table 12. Global Key Manufacturers of Mebendazole API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mebendazole API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mebendazole API as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mebendazole API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mebendazole API Sales by Region (2020-2025) & (Tons)
 Table 18. Global Mebendazole API Sales Market Share by Region (2020-2025)
 Table 19. Global Mebendazole API Sales by Region (2026-2031) & (Tons)
 Table 20. Global Mebendazole API Sales Market Share by Region (2026-2031)
 Table 21. Global Mebendazole API Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mebendazole API Revenue Market Share by Region (2020-2025)
 Table 23. Global Mebendazole API Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mebendazole API Revenue Market Share by Region (2026-2031)
 Table 25. North America Mebendazole API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mebendazole API Sales by Country (2020-2025) & (Tons)
 Table 27. North America Mebendazole API Sales by Country (2026-2031) & (Tons)
 Table 28. North America Mebendazole API Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mebendazole API Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mebendazole API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mebendazole API Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Mebendazole API Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Mebendazole API Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mebendazole API Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mebendazole API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mebendazole API Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Mebendazole API Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Mebendazole API Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mebendazole API Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mebendazole API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mebendazole API Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Mebendazole API Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Mebendazole API Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mebendazole API Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mebendazole API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mebendazole API Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Mebendazole API Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Mebendazole API Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mebendazole API Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mebendazole API Sales (Tons) by Type (2020-2025)
 Table 51. Global Mebendazole API Sales (Tons) by Type (2026-2031)
 Table 52. Global Mebendazole API Sales Market Share by Type (2020-2025)
 Table 53. Global Mebendazole API Sales Market Share by Type (2026-2031)
 Table 54. Global Mebendazole API Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mebendazole API Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mebendazole API Revenue Market Share by Type (2020-2025)
 Table 57. Global Mebendazole API Revenue Market Share by Type (2026-2031)
 Table 58. Global Mebendazole API Price (US$/kg) by Type (2020-2025)
 Table 59. Global Mebendazole API Price (US$/kg) by Type (2026-2031)
 Table 60. Global Mebendazole API Sales (Tons) by Application (2020-2025)
 Table 61. Global Mebendazole API Sales (Tons) by Application (2026-2031)
 Table 62. Global Mebendazole API Sales Market Share by Application (2020-2025)
 Table 63. Global Mebendazole API Sales Market Share by Application (2026-2031)
 Table 64. Global Mebendazole API Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mebendazole API Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mebendazole API Revenue Market Share by Application (2020-2025)
 Table 67. Global Mebendazole API Revenue Market Share by Application (2026-2031)
 Table 68. Global Mebendazole API Price (US$/kg) by Application (2020-2025)
 Table 69. Global Mebendazole API Price (US$/kg) by Application (2026-2031)
 Table 70. Dolphinpharma Company Information
 Table 71. Dolphinpharma Description and Business Overview
 Table 72. Dolphinpharma Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 73. Dolphinpharma Mebendazole API Product
 Table 74. Dolphinpharma Recent Developments/Updates
 Table 75. Anant Pharmaceuticals Company Information
 Table 76. Anant Pharmaceuticals Description and Business Overview
 Table 77. Anant Pharmaceuticals Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 78. Anant Pharmaceuticals Mebendazole API Product
 Table 79. Anant Pharmaceuticals Recent Developments/Updates
 Table 80. Fengchen Group Co.,Ltd Company Information
 Table 81. Fengchen Group Co.,Ltd Description and Business Overview
 Table 82. Fengchen Group Co.,Ltd Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 83. Fengchen Group Co.,Ltd Mebendazole API Product
 Table 84. Fengchen Group Co.,Ltd Recent Developments/Updates
 Table 85. Solara Active Pharma Sciences Company Information
 Table 86. Solara Active Pharma Sciences Description and Business Overview
 Table 87. Solara Active Pharma Sciences Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. Solara Active Pharma Sciences Mebendazole API Product
 Table 89. Solara Active Pharma Sciences Recent Developments/Updates
 Table 90. Conscientia Industrial Co., Ltd Company Information
 Table 91. Conscientia Industrial Co., Ltd Description and Business Overview
 Table 92. Conscientia Industrial Co., Ltd Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Conscientia Industrial Co., Ltd Mebendazole API Product
 Table 94. Conscientia Industrial Co., Ltd Recent Developments/Updates
 Table 95. Cipla Company Information
 Table 96. Cipla Description and Business Overview
 Table 97. Cipla Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 98. Cipla Mebendazole API Product
 Table 99. Cipla Recent Developments/Updates
 Table 100. K.A.Malle Company Information
 Table 101. K.A.Malle Description and Business Overview
 Table 102. K.A.Malle Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 103. K.A.Malle Mebendazole API Product
 Table 104. K.A.Malle Recent Developments/Updates
 Table 105. Optimus Drugs Pvt Ltd Company Information
 Table 106. Optimus Drugs Pvt Ltd Description and Business Overview
 Table 107. Optimus Drugs Pvt Ltd Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 108. Optimus Drugs Pvt Ltd Mebendazole API Product
 Table 109. Optimus Drugs Pvt Ltd Recent Developments/Updates
 Table 110. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Company Information
 Table 111. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Description and Business Overview
 Table 112. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 113. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Mebendazole API Product
 Table 114. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Recent Developments/Updates
 Table 115. Jiangsu Quality Horizons Pharmtech Co., Ltd. Company Information
 Table 116. Jiangsu Quality Horizons Pharmtech Co., Ltd. Description and Business Overview
 Table 117. Jiangsu Quality Horizons Pharmtech Co., Ltd. Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 118. Jiangsu Quality Horizons Pharmtech Co., Ltd. Mebendazole API Product
 Table 119. Jiangsu Quality Horizons Pharmtech Co., Ltd. Recent Developments/Updates
 Table 120. Enomark Pharma Company Information
 Table 121. Enomark Pharma Description and Business Overview
 Table 122. Enomark Pharma Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 123. Enomark Pharma Mebendazole API Product
 Table 124. Enomark Pharma Recent Developments/Updates
 Table 125. Eurosoft Pharma Private Limited Company Information
 Table 126. Eurosoft Pharma Private Limited Description and Business Overview
 Table 127. Eurosoft Pharma Private Limited Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 128. Eurosoft Pharma Private Limited Mebendazole API Product
 Table 129. Eurosoft Pharma Private Limited Recent Developments/Updates
 Table 130. Sudarshan Pharma Industries Limited Company Information
 Table 131. Sudarshan Pharma Industries Limited Description and Business Overview
 Table 132. Sudarshan Pharma Industries Limited Mebendazole API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 133. Sudarshan Pharma Industries Limited Mebendazole API Product
 Table 134. Sudarshan Pharma Industries Limited Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Mebendazole API Distributors List
 Table 138. Mebendazole API Customers List
 Table 139. Mebendazole API Market Trends
 Table 140. Mebendazole API Market Drivers
 Table 141. Mebendazole API Market Challenges
 Table 142. Mebendazole API Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mebendazole API
 Figure 2. Global Mebendazole API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mebendazole API Market Share by Type: 2024 & 2031
 Figure 4. Purity≥99% Product Picture
 Figure 5. Purity<99% Product Picture
 Figure 6. Global Mebendazole API Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Mebendazole API Market Share by Application: 2024 & 2031
 Figure 8. Tablet
 Figure 9. Solvent
 Figure 10. Others
 Figure 11. Global Mebendazole API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Mebendazole API Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Mebendazole API Sales (2020-2031) & (Tons)
 Figure 14. Global Mebendazole API Average Price (US$/kg) & (2020-2031)
 Figure 15. Mebendazole API Report Years Considered
 Figure 16. Mebendazole API Sales Share by Manufacturers in 2024
 Figure 17. Global Mebendazole API Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Mebendazole API Players: Market Share by Revenue in Mebendazole API in 2024
 Figure 19. Mebendazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Mebendazole API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Mebendazole API Sales Market Share by Country (2020-2031)
 Figure 22. North America Mebendazole API Revenue Market Share by Country (2020-2031)
 Figure 23. United States Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Mebendazole API Sales Market Share by Country (2020-2031)
 Figure 26. Europe Mebendazole API Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Mebendazole API Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Mebendazole API Revenue Market Share by Region (2020-2031)
 Figure 34. China Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Mebendazole API Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Mebendazole API Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Mebendazole API Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Mebendazole API Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Mebendazole API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Mebendazole API by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Mebendazole API by Type (2020-2031)
 Figure 53. Global Mebendazole API Price (US$/kg) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Mebendazole API by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Mebendazole API by Application (2020-2031)
 Figure 56. Global Mebendazole API Price (US$/kg) by Application (2020-2031)
 Figure 57. Mebendazole API Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Albendazole API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fenbendazole API Market Research Report 2025
Pharmaceutical Grade Albendazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Memantine Hydrochloride API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Miglustat API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Doxofylline API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Epalrestat API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metronidazole API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Api Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Constrained Peptide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Amphotericin B API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dengue Fever Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Chemical API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions